chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse who reported one case involving a household contact of a person vaccinated with zoster vaccine live (Oka/Merck) who developed shingles. She confirmed that the vaccinee in this case did not develop a rash or shingles. She did not have any other details about the household contact, including whether they had a history of chickenpox. The possibility of PCR for this case was discussed, but the nurse explained that she learned of this case several weeks ago and thought that the household contact might have recovered. The VZVIP program and specimen collection was discussed. It is unknown if medical attention was sought. There was no product quality complaint. This is one of several reports received from the same source. The nurse mentioned that some of the cases were reported to VAERS. Additional information is not expected.
awoke noc of vax w/stiff arms, legs & neck, couldn't move for awhile then when up vomiting & retching;better w/in 36hr;
got booster this past week.; a lot of blood came out of the shot spot once the shot was administered; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  An adult female patient received bnt162b2 (BNT162B2), administration date Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose Number: 1, Manufacturer unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose Number: 2, Manufacturer unknown), for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset Dec2021, outcome "unknown", described as "got booster this past week."; VACCINATION SITE HAEMORRHAGE (non-serious) with onset Dec2021, outcome "unknown", described as "a lot of blood came out of the shot spot once the shot was administered".  The lot number for bnt162b2 was not provided and will be requested during follow up.
I had my second Maderna shot at 10:30 am. No problem with my first one three weeks ago. At 10:00 pm I started to get extremely cold and could not get warm. At 10:45 my upper body started shaking very, very bad. I couldn't control the shaking and my teeth were chattering.  I had to lay down and put my arms under my body to keep them from shaking and I was so cold even though I was wearing warm things and under a comforter.  The shaking lasted an hour and a half. I took my temperature  during the night and it was 102. I am very week this morning, temp. is 99.9.  I was expecting the temperature and pain in the injection site but I can't find out anywhere on line whether the uncontrollable shaking was normal for the second shot.  .
That night after getting the first vaccine, I started feeling really sick. I felt like I had a fever of about 99. When I checked it, it was 99. I was exhausted and had a headache. The next night, I was so sick and felt so tired. I started having sinus drainage. I started having yellow mucus. I felt fluid in my head. I started thinking that maybe I should go to the doctor. On Feb 5, I was feeling a slightly scratchy throat. I still had the headache, still had sneezing and coughing, still had stomach issues, and I still had sinus drainage. Over the weekend, I started feeling extreme pain and chills. All of a sudden, I started getting night chills. I was having constant pain and chills. I couldn't get any sleep. I found blood in my mucus. On Feb 9, I started feeling a fever. I went to see the Dr. and I was told that my blood sugar was around 600. My fever went up to 99.7. I have fever and chills until about Feb. 15th. I was written a note to be off work Feb 12th-15th. I do virtual teaching at home. I went to see a few physicians. I went to my physicians on Feb 16. I told them I was feeling fever and chills. I was diagnosed with Type 2 Diabetes. I did not have any blood sugar problems until after the vaccination. At one point, my fever went up to 102. I was having trouble moving so I gained some weight. I couldn't keep down some of the food I was eating. I was not eating that much during that time frame though. I was throwing up some because I couldn't stomach the food I was eating. I sat and waited it out for about a week. Around Feb 28th, things started to get better. I finally was feeling a little better, but I knew I was having to go get my second vaccine. I sought advice on what I could do to help protect myself for the 2nd shot. I had to get it for my job. I just felt too sick to do anything. I could barely teach. This whole thing has been very annoying and frustrating for me. I fight every single day because of my injuries to get through my regular days. This has also now caused a lot of stress.
This spontaneous report as received from a Licensed Practical Nurse refers to a 6 month old patient of unknown gender. No pertinent medical history, concurrent conditions, drug reactions, allergies or concomitant therapies were provided. On 09-JUL-2018, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # N028258, expiration date on 30-MAY-2019), oral for prophylaxis (dosage schedule was not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 0 to 1 (1.4) degrees Celsius for 3 hours. Digital Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1807USA004691; US-009507513-1807USA012290; US-009507513-1807USA012291; US-009507513-1807USA012292; US-009507513-1807USA012304; US-009507513-1807USA012294; US-009507513-1807USA012295; US-009507513-1807USA012296; US-009507513-1807USA012297; US-009507513-1807USA012298; US-009507513-1807USA012299; US-009507513-1807USA012300; US-009507513-1807USA012301; US-009507513-1807USA012302; US-009507513-1807USA012303; US-009507513-1807USA012289; US-009507513-1807USA012287; US-009507513-1807USA012286; US-009507513-1807USA012293.
Woke at 3:30am with temp of 102.7, chest heaviness, upper right side of body very hot from shoulder, arm to chest, left side of body was cool to touch, chills, dizziness, headache, feels weak, cough when taking deep breath, nausea.
This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported.
Significant fatigue, mild body aches, slight disorientation, slightly elevated temperature (did not measure) for 18 hours after initial onset of symptoms.  Tenderness at injection site 72 hrs after injection.
This spontaneous report was received from a medical assistant and refers to a 23-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-JUL-2015, the patient was vaccinated with the first dose of GARDASIL 9 intramuscularly (dose, lot# and expiration date were not reported). On 06-OCT-2015, the patient was vaccinated with the second dose of GARDASIL 9 intramuscularly (dose, lot# and expiration date were not reported). On 17-JAN-2018, the patient returned to the physician's office to receive the third dose of GARDASIL 9. There was no adverse effect reported.
Case number PHEH2012US020474, is an initial spontaneous report received from a pharmacist on 15 Oct 2012. This report refers to 75 year old male patient. He was vaccinated with FLUVIRIN (batch number: 1204101), intramuscular in Oct 2012 (exact date not reported). A couple of hours after vaccination the patient experienced seizure (caller states that this occurred few days ago but does not know the exact date of vaccination). The patient had a seizure earlier that day and did not go to the doctor before FLUVIRIN administration. Pharmacist states that the doctor thought it was caused by hypoglycemia (went down to about 36). Event outcome, seriousness and causality were not reported. No further information was provided.
Patient admitted to the hospital on 5/11/21 with nonrheumatic aortic valve stenosis and had heart catheterization. Then on 5/17/21 patient presented to the ED and was subsequently hospitalized with chest pain.
Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Pt was administered Pfizer instead of Moderna which is what she was supposed to get for her second dose. Pt had no reactions while she was waiting in pharmacy
Stomach pain; Diarrhea; Inflammation of the armpit limp nodes that is really pain full; Pain in the right arm where the vaccine was administered; Eruption in the right arm where the vaccine was applied.; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), DIARRHOEA (Diarrhea), LYMPHADENITIS (Inflammation of the armpit limp nodes that is really pain full), VACCINATION SITE PAIN (Pain in the right arm where the vaccine was administered) and VACCINATION SITE RASH (Eruption in the right arm where the vaccine was applied.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), DIARRHOEA (Diarrhea), LYMPHADENITIS (Inflammation of the armpit limp nodes that is really pain full), VACCINATION SITE PAIN (Pain in the right arm where the vaccine was administered), VACCINATION SITE RASH (Eruption in the right arm where the vaccine was applied.) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), DIARRHOEA (Diarrhea), LYMPHADENITIS (Inflammation of the armpit limp nodes that is really pain full), VACCINATION SITE PAIN (Pain in the right arm where the vaccine was administered), VACCINATION SITE RASH (Eruption in the right arm where the vaccine was applied.) and FATIGUE (Very tired) outcome was unknown.            No concomitant medication details was provided. no reaction during the main vaccination series. took Tylenol but was not very effective
diagnosed with Covid; diagnosed with Covid; This is a spontaneous report from a contactable consumer or other non health professional. A contactable female patient of an unspecified age received bnt162b2 (BNT162B2; Batch/Lot number: unknown, Expiry date: Not provided), dose 1 via an unspecified route of administration on an unspecified date as SINGLE DOSE for COVID-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported. The patient information about other products were not reported. On 20Dec2020, the patient was diagnosed with covid (covid-19). The outcome of the events were unknown.  Information on the lot/batch number has been requested.
Shortness of breath; fever; nausea; body aches; chills; headache; tired; This is a spontaneous report from a non-contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 02Ma2021 at 08:00 (at the age of 37-year-old), dose 2, single for COVID-19 immunisation. Medical history included blood clotting disorder. Concomitant medications included apixaban (ELIQUIS) and vitamin B complex (VITAMIN B). The patient previously took cefalexin monohydrate (KEFLEX), levofloxacin (LEVAQUIN), azithromycin and had allergy to these medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. On 02Mar2021 at 23:00, the patient experienced shortness of breath, fever, nausea, body aches, chills, headache, and was tired. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
this is 1 of 3 pt from this facility to devel an inj site rxn characterized by swelling & soreness p/vax;
My daughter had 4 mild seizures after she received the 2nd dose of the Pfizer. Her first seizure was 25 minutes after and other seizures were 25-30 minutes apart until I gave her Clonazepam for her on going seizures.
Red rash all over body; Hives on legs, butt, stomach, lower stomach, arms, hands, feet, face, neck and back; This is a spontaneous report from a contactable consumer, the patient.  A 31-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL4262), via an unspecified route of administration in the left arm on 27Jan2021 at 14:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 29Jan2021 at 15:00, the patient experienced red rash all over body and hives on legs, butt, stomach, lower stomach, arms, hands, feet, face, neck and back. The events required a visit to the emergency room and physician's office. The patient was treated with methyprednisolone (MANUFACTURER UNKNOWN), epinephrine (MANUFACTURER UNKNOWN), and diphenhydramine (MANUFACTURER UNKNOWN). The clinical outcomes red rash all over body and hives were not recovered.
Fairly strong all over muscle pain, especially at injection site, some nausea and stomach pain, some shivering, inability to sleep for 5-6 hours. Some muscle pain at current time, 20 hours after injection.
Information has been received on 25-MAR-2019 from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 15-APR-2014, the patient was administered the ZOSTAVAX vaccine (lot# and route not specified) by a healthcare provider. On an unspecified date, the patient was treated by a nurse practitioner for shingles as a result of vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
fever; aphasia/could not talk; This spontaneous report was received from a female patient of unknown age referring to herself. The patient's medical history included renal transplant. Her concomitant medications and drug reactions or allergies were not provided.  On an unspecified date in November 2011, the patient was vaccinated with either pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) or pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) (formulation, strength, dose, anatomical dose, route of administration, lot # and expiration date were not reported for both) as prophylaxis (the patient could not remember which). She reported that she developed a fever about 3-4 hours after receiving the vaccine and had to be taken to the emergency room by ambulance after the fever continued to rise. She was hospitalized for 2-3 nights and was not able to remember much from the hospitalization. She reports that when she woke up in the hospital she could not talk and experienced aphasia that the doctor said could have been results of the high fever. Unspecified treatment was given for the events. The outcome of the events was reported as recovered about 1 week later.  The relatedness between the suspect therapies and the events was not provided.
red spot  in the arm and it is swollen; red spot  in the arm and it is swollen; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red spot  in the arm and it is swollen), VACCINATION SITE SWELLING (red spot  in the arm and it is swollen) and FATIGUE (feeling tired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011f21a, 031a21a and 002b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Dementia (taking medication for dementia) and Heart disorder (taking medication for heart). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), APIXABAN (ELIQUIS), METFORMIN and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Oct-2021, the patient experienced VACCINATION SITE ERYTHEMA (red spot  in the arm and it is swollen), VACCINATION SITE SWELLING (red spot  in the arm and it is swollen) and FATIGUE (feeling tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (red spot  in the arm and it is swollen), VACCINATION SITE SWELLING (red spot  in the arm and it is swollen) and FATIGUE (feeling tired) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also included medication for dementia and medication for the patient's heart.
Patient was given a dose of Meningitis B vaccine (TruMenba) instead of Meningitis ACWY vaccine (MenActra). Spoke with Mom and informed her of the situation. Patient will receive 1 dose of Meningitis ACWY vaccine at next well visit (12 y/o) and will still need 2 doses of Meningitis B vaccine at 18 y/o well visit.
I experienced severe back and chest pain. I thought I was having a heart attack. I took my blood pressure. It was around 185/110. I watched my blood pressure. It stayed high, but I went to sleep. The next day, I checked my blood pressure. It was still high, but it had improved. I took it easy and kept an eye on it. It kept improving. By Friday, it was normal, but I went to see a Cardiologist on December 14, 2022 anyway.
First dose 3/11/21 no problems.  Nurse at clinic placed sticker for dose 2 over dose 1 lot number so unreadable.  Dose 2 : headache, fatigue, body aches and throat very swollen  at 24 hours. Within 72 hours developed hives starting in middle of back and spread to cover entire body including scalp. Not on palms or soles of feet. Eyes became very red and hives and eyes  and swollen throat took several days to return to normal.  Took benedryl, Allegra, Claritin for allergy symptoms. Very remarkable and thought about going to ER .
Right Arm pain limiting range of motion with shooting pain down right arm, low grade fever, malaise, body aches, nausea, decreased appetite.
Vaccine given at approximately 11:10. Patient states "light headed". Noted to be diaphoretic and pale. Vitals taken. Patient placed on floor with 2 assist. Dr. on site. Patient recovered quickly with color (skin) improvement. He was moved by wheelchair and brought to the clinic's first aid room. Patients vitals obtained and within normal limits. No further issues noted. Patient left clinic for home in the care of his wife.
On 10/19/22, 16 days after receiving updated pfizer booster, pt started an "unbearable headache" on left side of head. It was so bad, with no relief, she went to the hospital on 10/20/22 where she was diagnosed with having a stroke on the left side. She is not sure the exact type, but believes it was a TIA. She remained in hospital for 11 days. Since then, she has recovered, but has eye twitching on the right side she is not sure if it is related. She has also been referred to and electrophysiologist due to an irregular heartbeat they found on 12/29/22.  Patient is just now reporting this to me because we administered the shot at local Pharmacy and she just heard the reports of stroke after updated booster. This is when she put "two and two together" and thought it should be reported.
SERIOUSLY ILL; This spontaneous report received from a consumer via social media via a company representative concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number were not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced seriously ill. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of seriously ill was not reported. This report was non-serious. This case, from the same reporter is linked to 20220236894.
Red and swollen patch around entire outer arm about 3-4 inches tall.  Hot to the touch, reports temped at 100 degrees F.  Lasting 7 days so far.  Doctor recommended icing and reporting to VAERS.
Pt. in clinic about 2 wks following vaccination. Reports possible cause MENVEO.
4-23-2012. Flu like sx; achy, tired. Low grade fever 100.2.
Information has been received from a physician concerning a 67 year old male patient, who on an unknown date was placed on therapy with ZOSTAVAX (route and lot # not reported). It was reported that, on an unknown date after receiving ZOSTAVAX, the patient's creatinine level "spiked up to 3.6" and was "now 1.8". It was also reported that the patient had not felt well since he had received the vaccine. The patient sought an unspecified medical attention on an unknown date. The outcome of patient's creatinine level spiked up and feeling unwell was reported as not recovered. The relatedness for patient's symptoms was unknown for ZOSTAVAX. Additional information has been requested.
numbing around the lips shortly after administration of Moderna Vaccine. symptoms resolved within 1/2 hour and patient left